Skip to content

Can Nurtec Stop a Migraine? Understanding this Dual-Action CGRP Blocker

5 min read

In clinical trials, 59.3% of patients taking Nurtec ODT experienced pain relief at two hours for acute treatment, demonstrating its effectiveness in stopping migraines for many people. Nurtec, or rimegepant, is a significant advancement in the pharmacology of migraine management as a CGRP receptor antagonist.

Quick Summary

Nurtec (rimegepant) is a CGRP antagonist approved to both treat and prevent migraines. As an orally disintegrating tablet, it works by blocking a key protein involved in migraine pain, CGRP, providing relief for many patients.

Key Points

  • Dual Action: Nurtec (rimegepant) is uniquely approved for both acute treatment of migraine attacks and preventive treatment of episodic migraine.

  • CGRP Blocker: As a CGRP receptor antagonist, Nurtec works by blocking the pain-signaling protein CGRP, addressing a root cause of migraine rather than simply constricting blood vessels like older triptan medications.

  • Proven Efficacy: In clinical trials, Nurtec demonstrated significant pain relief and pain freedom for many patients within two hours of an acute migraine attack, with benefits lasting up to 48 hours.

  • Favorable Side Effect Profile: Common side effects are generally mild and include nausea and stomach pain, with a lower risk of cardiovascular side effects compared to triptans.

  • Easy Administration: Nurtec is an orally disintegrating tablet (ODT) that dissolves quickly on or under the tongue, making it convenient for patients with nausea or who need relief without water.

  • Important Interactions: It is vital to consult a healthcare provider about potential interactions with other medications and supplements, as Nurtec should be avoided with strong CYP3A4 inhibitors and grapefruit products.

In This Article

How Nurtec Works to Block a Migraine

Unlike older migraine drugs, such as triptans, which constrict blood vessels, Nurtec (rimegepant) works differently by targeting a protein called calcitonin gene-related peptide, or CGRP. During a migraine attack, the body releases CGRP, which plays a critical role in the pain and inflammation associated with a migraine. Nurtec is a CGRP receptor antagonist, meaning it effectively blocks CGRP from binding to its receptors. By blocking these receptors, Nurtec helps to prevent the pain signals and inflammatory processes that cause migraine symptoms, addressing a root cause of the condition. This targeted mechanism is especially beneficial for patients who have cardiovascular risk factors, as triptans are often avoided in this population due to their vasoconstrictive properties. The orally disintegrating tablet (ODT) formulation also offers a key advantage, as it dissolves quickly on or under the tongue without water, which is helpful for patients experiencing nausea or who need to take medication on the go.

Can Nurtec Stop a Migraine? Efficacy for Acute Attacks

For those suffering from an acute migraine attack, the question of efficacy is paramount. Clinical trial data shows that Nurtec is indeed effective at treating an ongoing migraine. In one study, Nurtec ODT demonstrated superior results compared to a placebo at the two-hour mark. Key efficacy findings for acute treatment include:

  • Pain Relief: 59.3% of patients taking Nurtec experienced pain relief, compared to 43.3% on placebo.
  • Pain Freedom: 21.2% of patients achieved complete pain freedom, versus 10.9% for placebo.
  • Sustained Benefit: For many, the relief from pain can last for up to 48 hours.
  • Freedom from Most Bothersome Symptom: In the same study, 35.1% of patients achieved freedom from their most bothersome symptom (e.g., sensitivity to light or sound, nausea) compared to 26.8% on placebo.

Some patients may even experience pain relief in as little as 60 minutes after taking the medication, allowing them to return to their normal daily activities sooner.

The Dual-Action Advantage: Nurtec for Prevention

Beyond its use as an acute treatment, Nurtec is also approved for the preventive treatment of episodic migraine. This makes it a unique and flexible option, as it is the first and only oral CGRP receptor antagonist with this dual indication. For prevention, patients take Nurtec on a regular schedule. Clinical trials showed that patients taking Nurtec regularly experienced a greater reduction in monthly migraine days compared to those on placebo. The preventive effects were noticeable for some as early as the first week of treatment, with significant reductions observed between weeks 9 and 12.

Comparison: Nurtec vs. Triptans and Other Gepants

For decades, triptans have been a standard for acute migraine relief, but Nurtec and other CGRP antagonists offer important alternatives for many patients. The following table compares key differences between Nurtec and triptans, as well as another oral gepant, Ubrelvy.

Feature Nurtec (rimegepant) Triptans (e.g., Sumatriptan) Ubrelvy (ubrogepant)
Mechanism CGRP receptor antagonist, does not constrict blood vessels Serotonin (5-HT1B/1D) receptor agonist; constricts blood vessels CGRP receptor antagonist
Approved Uses Acute treatment and preventive treatment of episodic migraine Acute treatment only Acute treatment only
Cardiovascular Risk Considered generally safer for patients with cardiovascular risk factors Contraindicated or used with caution in patients with heart disease or stroke risk Generally low risk
Formulation Orally Disintegrating Tablet (ODT), no water needed Oral tablets, nasal spray, injections Oral tablets, swallowed whole
Dosing for Acute Use Single dose, not to exceed a certain frequency Varies by medication; may repeat dose as directed Varies by dosage; may repeat dose as directed
Common Side Effects Nausea, stomach pain Tingling, numbness, fatigue, dizziness Nausea, sleepiness, dry mouth

Nurtec's dual function and suitability for patients with cardiovascular concerns make it a valuable addition to migraine treatment options. Unlike Ubrelvy, which is only for acute attacks, Nurtec’s dual indication simplifies treatment for many patients who need both acute and preventive management.

Administration and Important Safety Information

Taking Nurtec ODT correctly is important for maximizing its benefits and ensuring safety. For both acute and preventive use, the medication is taken as prescribed.

  • Administration Steps: To take Nurtec ODT, ensure hands are dry before peeling back the foil from the blister pack. Place the tablet on or under the tongue and allow it to dissolve completely, which happens within seconds. No water is needed.
  • Dosing Schedule: For acute treatment, take as needed, following your healthcare provider's instructions and not exceeding the recommended frequency. For preventive treatment, take regularly as prescribed, generally every other day.

Potential Side Effects and Contraindications

While generally well-tolerated, Nurtec does have potential side effects and precautions to consider:

  • Common Side Effects: The most common side effects reported are nausea (2.7%) and indigestion or stomach pain (2.4%).
  • Serious Allergic Reactions: Though rare, hypersensitivity reactions can occur, including swelling of the face, mouth, tongue, or throat, and trouble breathing. This can happen days after taking the medication.
  • Drug Interactions: Certain medications, such as strong CYP3A4 inhibitors (e.g., ketoconazole) and strong or moderate CYP3A inducers (e.g., St. John's Wort), can interact with Nurtec. Your doctor or pharmacist should review all medications, including supplements, to avoid interactions.
  • Grapefruit: Avoid consuming grapefruit and grapefruit juice, as they can interfere with how your body processes Nurtec.
  • Specific Conditions: Nurtec is not recommended for patients with severe liver impairment or end-stage kidney disease.

Conclusion: A Powerful Option for Migraine Management

Ultimately, the question of "can Nurtec stop a migraine?" has a clear answer for many patients: yes. Its efficacy has been demonstrated in clinical trials, providing significant pain relief and pain freedom for acute attacks. What makes Nurtec particularly innovative is its ability to also serve as a preventive medication for episodic migraine, allowing some patients to manage their condition with a single drug. By targeting the CGRP pathway, Nurtec offers a mechanism of action that avoids the vasoconstrictive effects of triptans, making it a safer option for individuals with cardiovascular concerns. While side effects are generally mild, it is crucial to discuss any potential risks, interactions, and suitability with a healthcare provider. With its dual functionality and favorable tolerability profile for many, Nurtec has emerged as a valuable and groundbreaking tool in the comprehensive management of migraine.


  • Disclaimer: This information is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment.

FDA Drug Labeling for Nurtec ODT

Frequently Asked Questions

For acute treatment of a migraine, Nurtec can start providing pain relief in as little as 60 minutes for some patients, with significant pain relief observed within two hours in clinical trials.

Nurtec and triptans have different mechanisms and effectiveness can vary by patient. Nurtec offers a targeted CGRP-blocking action, potentially with fewer side effects than triptans, and is an option for those with cardiovascular concerns who cannot take triptans.

Yes, Nurtec is FDA-approved for both acute and preventive treatment of migraine. If using it for prevention, a patient can still use Nurtec for an acute attack if needed, but should follow their healthcare provider's instructions regarding frequency of use.

To take Nurtec ODT, ensure your hands are dry. Peel back the foil on the blister pack, place the tablet on or under your tongue, and allow it to dissolve completely. It is not meant to be swallowed whole with water.

The most common side effects reported for Nurtec are nausea (less than 3% of patients) and stomach pain or indigestion.

There is no evidence to suggest that Nurtec causes rebound headaches (medication overuse headache) when used as directed for either acute or preventive treatment.

You should not take Nurtec if you have a history of a severe allergic reaction to its ingredients. It is also not recommended for patients with severe liver impairment, end-stage kidney disease, or when taking strong inhibitors or inducers of certain enzymes like CYP3A4.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.